Medical Devices Philippines

Philippines Hormone Testing at Home Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Philippines Hormone Testing at Home Market Industry Trends and Forecast to 2034: Segmented by (Hormone, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Philippines · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.9 Mn Placeholder estimate
Estimate 2025 $2.1 Mn 0.2% of the global market
Projected 2034 $5.0 Mn 143.6% Adds $3.0 Mn over 9 forecast years
CAGR 2025–2034 10.4% Faster than 61% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Philippines is 0.24% of the global market.
  • In APAC, the largest is China at $61.6 Mn.
  • Fastest growing: India at 12.6% a year.
  • Philippines ranks 6th of 10 by size in APAC.

Market size projection

Philippines

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$3.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hormone Testing at Home Market market size by year, Philippines
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.9 Mn — —
2025 (base) $2.1 Mn +$0.2 Mn —
2026 (forecast) $2.3 Mn +$0.2 Mn +10.4%
2027 (forecast) $2.5 Mn +$0.2 Mn +21.9%
2028 (forecast) $2.8 Mn +$0.3 Mn +34.6%
2029 (forecast) $3.1 Mn +$0.3 Mn +48.6%
2030 (forecast) $3.4 Mn +$0.3 Mn +64%
2031 (forecast) $3.8 Mn +$0.4 Mn +81.1%
2032 (forecast) $4.1 Mn +$0.4 Mn +99.9%
2033 (forecast) $4.6 Mn +$0.4 Mn +120.7%
2034 (forecast) $5.0 Mn +$0.5 Mn +143.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $847.0 Mn
  2. US $379.4 Mn
  3. North America $355.7 Mn
  4. APAC $158.4 Mn
  5. Europe $135.3 Mn
  6. Canada $65.0 Mn
  7. China $61.6 Mn
  8. Japan $45.4 Mn
  9. Germany $32.0 Mn
  10. Latin America $33.3 Mn
  11. Middle East $31.4 Mn
  12. UK $22.9 Mn
  13. France $21.5 Mn
  14. Brazil $21.9 Mn
  15. Italy $17.2 Mn
  16. Ecuador $17.2 Mn
  17. Spain $16.3 Mn
  18. India $16.0 Mn
  19. Mexico $14.4 Mn
  20. Saudi Arabia $13.7 Mn
  21. Africa $12.5 Mn
  22. Australia $11.7 Mn
  23. New Zealand $8.2 Mn
  24. Russia $7.5 Mn
  25. South Africa $5.7 Mn
  26. UAE $4.8 Mn
  27. Egypt $2.4 Mn
  28. Philippines (this report) $2.1 Mn
  29. Hong Kong $1.4 Mn
  30. Malaysia $1.2 Mn
  31. Singapore $1.1 Mn
  32. Thailand $1.1 Mn
  33. Kenya $0.6 Mn

Report snapshot

Philippines Hormone Testing at Home Market Analysis at a glance
Market size, 2025$2.1 Mn placeholder estimate
Forecast, 2034$5.0 Mn placeholder estimate
Growth (CAGR), 2025–203410.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsHormone, sample and end user (see all)
Key playersEverlywell, LetsGetChecked, Thorne, Mira, Hims & Hers Health (see all)
Regulator in the PhilippinesFDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Philippines Hormone Testing at Home Market Analysis Executive Summary

At-home hormone tests measure hormones such as estrogen, thyroid, cortisol and testosterone from finger-prick blood or saliva.

Key segments of the hormone Testing at Home market include hormone (Female Sex Hormones, Thyroid and Cortisol) and sample (Blood, Saliva and Urine).

Bar chart: Philippines Hormone Testing at Home market size, 2024–2034, placeholder estimates. $1.9 Mn in 2024, $2.1 Mn in 2025 and $5.0 Mn in 2034, 10.4% CAGR.
Philippines Hormone Testing at Home market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Philippines Hormone Testing at Home Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the hormone Testing at Home market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the hormone Testing at Home market.

Competitive Landscape for Hormone Testing at Home Market in Philippines

The hormone Testing at Home market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hormone Testing at Home Market in Philippines

Hormone Testing at Home in the Philippines: rules and payment

Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).⁠[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.⁠[2]

[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[2] PhilHealth. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hormone Testing at Home products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Philippines.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hormone Testing at Home right now, from free public sources.

Latest research 4 papers since 2021 (worldwide)

  1. Association Between Hormone Variability and Anaerobic Performance in Recreationally Active Women: An Exploratory Study Using Mixed-Effect Location Scale Models. Journal of strength and conditioning research, 2026
  2. A Novel Approach to Characterization of the Female Hormone Profile: Feasibility and Research Application of Daily At-Home Urine Hormone Monitoring. Medicine and science in sports and exercise, 2026
  3. Menstrual tracking technologies and fertility: evaluating accuracy, utility, and impact on time to pregnancy. Fertility and sterility, 2026
  4. Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study. Reproductive biology and endocrinology : RB&E, 2022
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hormone Testing at Home in context

The Philippines compared

  • Health spending per person: 194 US$ per person (2023). World: 1,317 US$ per person (2023). 8th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 0.79 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 9th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 5.7% of people (2025). World: 10.4% of people (2025). 14th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hormone Testing at Home market in the Philippines?
Placeholder estimate: about $2.1 Mn in 2025, rising to about $5.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hormone Testing at Home market in the Philippines growing?
Placeholder estimate: about 10.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hormone Testing at Home market report cover?
The report splits the market by hormone (Female Sex Hormones, Thyroid, Cortisol, Testosterone), sample (Blood, Saliva, Urine) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hormone Testing at Home market?
Key players include Everlywell, LetsGetChecked, Thorne, Mira and Hims & Hers Health.
What is driving the Hormone Testing at Home market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.
Who regulates Hormone Testing at Home in the Philippines?
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA). Source: Food and Drug Administration Philippines. Checked 14 Nov 2026.
How is healthcare paid for in the Philippines?
PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member. Source: PhilHealth. Checked 14 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Hormone Testing at Home in Philippines? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Philippines

See all
Same topic, other categories

Related on women's health and diagnostics and lab testing

See the topic